Quest Diagnostics Inc (DGX)

DGX (NYSE:Health Services) EQUITY
$71.70
pos +0.00
+0.00%
Today's Range: 71.20 - 72.35 | DGX Avg Daily Volume: 1,574,800
Last Update: 05/01/15 - 4:01 PM EDT
Volume: 0
YTD Performance: 6.92%
Open: $0.00
Previous Close: $71.42
52 Week Range: $55.08 - $78.33
Oustanding Shares: 144,311,302
Market Cap: 10,267,785,289
6-Month Chart
TheStreet Ratings Grade for DGX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 14 14 11 12
Moderate Sell 1 1 1 0
Strong Sell 2 3 3 3
Mean Rec. 3.02 3.12 3.14 3.08
Latest Dividend: 0.38
Latest Dividend Yield: 2.13%
Dividend Ex-Date: 04/06/15
Price Earnings Ratio: 20.46
Price Earnings Comparisons:
DGX Sector Avg. S&P 500
20.46 20.30 28.23
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.89% 28.10% 21.98%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.00 -0.01 0.00
Net Income -33.00 0.16 0.05
EPS -31.20 0.30 0.09
Earnings for DGX:
EBITDA 1.29B
Revenue 7.44B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.24 $1.27 $4.78 $5.14
Number of Analysts 14 13 15 15
High Estimate $1.29 $1.31 $4.89 $5.32
Low Estimate $1.20 $1.23 $4.73 $4.96
Prior Year $1.08 $1.10 $4.10 $4.78
Growth Rate (Year over Year) 15.01% 15.10% 16.67% 7.54%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Update
Mar 27, 2015 | 7:59 AM EDT
Coverage of DGX was started with a Market Perform, JMP Securities said. Company is facing macro headwinds. 
Bearish
Mar 25, 2015 | 7:22 AM EDT
DGX was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on an $80 price target.
Here are healthcare stocks of all shares and sizes with strong charts.
Bullish
Mar 03, 2015 | 5:49 AM EST
DGX was upgraded from Hold to Buy, Canaccord Genuity said. $82 price target. Company is cutting costs and should see higher test volume...
Bearish
Feb 23, 2015 | 7:24 AM EST
DGX was downgraded to Underperform, Bank of America/Merrill Lynch said. $68 price target. Company appears to be growth slower than top ...

Get Some Positive Lab Results Real Money Pro($)

Try this options play for the sometimes volatile Bio-Reference Laboratories.
Bullish
May 08, 2014 | 7:58 AM EDT
DGX was upgraded to Neutral from Underperform, Bank of America/Merrill Lynch said. $58 price target. Had positive meetings with managem...
Bullish
Apr 14, 2014 | 8:19 AM EDT
Shares of DGX now seen reaching $62, according to Credit Suisse. Estimates also upped, given better reimbursement trends and the Solsta...
Update
Feb 25, 2014 | 7:12 AM EST
RBC Capital Markets Healthcare Conference
Bearish
Jan 31, 2014 | 8:10 AM EST
DGX cut its numbers, UBS said. 1Q14 expected to be impacted by sequestration and weather. $56 price target and Neutral rating. 

Columnist Conversations

Big day for McDonald's on Monday, a long awaited turnaround plan will be shared. A video from the company wil...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.